Join us for the 4th annual LSPN North America - Spring conference!
In response to the numerous requests for an even bigger conference programme, we are delighted to announce that LSPN Spring 2020 will now take place over two days, enabling even more networking opportunities and a packed programme of presentations and panel discussions. You wanted more round table discussion time, so this year’s conference enables you to join four 45 minute discussion groups of your choosing.
You told us that you wanted a networking dinner. So - brand new for 2020, we present you with the LSPN Gala Dinner!
Taking place on the evening of day one of the conference, the gala dinner and drinks reception is a great opportunity to relax after the conference, in the company of your fellow delegates, speakers and sponsors. Places at the dinner are limited, so we urge you to sign up to attend the Gala Dinner when you book your delegate place so as not to miss out.
Over 50% of LSPN network attendees are in-house counsel
Brought to you by Life Sciences Intellectual Property Review, the 4th Annual Life-Sciences Patent Network NORTH AMERICA is the first of the 2020 patent conference series, which presents an unrivalled gathering of in-house patent counsel from established and fledgling pharmaceutical and biotechnology companies coming together to listen to updates on patent prosecution and enforceability from global jurisdictions, meet in informal discussion groups, and source specialist IP attorneys who can assist them with their IP portfolio strategies over the coming year.
The conference, taking place once again in Boston, MA on 13-14th May 2020, provides delegates with an invaluable opportunity to gain insight into the sector issues of critical current importance; listen to best-in-class case studies; keep abreast of the likely forward impact of key judgements and political jolts; and network with global patent peers.
Following on from the hugely successful LSPN conferences in London and Singapore, the Boston conference takes a broad global view of the patent protection landscape and then delves deeper into the topics of specific current interest. Extended round table discussion groups enable a couple of hours to be spent in small groups, sharing views on a range of topics of the delegates’ choosing. For fledgling bio-pharma manufacturers, the conference features a hugely popular open clinic to enable in-house counsel to quiz specialist private patent attorneys from around the globe on their own specific pressing patent issues.
As well as conference presentations and the in-depth panel discussion along with audience Q&A, sessions and the discussion groups, a great deal of networking time is set aside throughout the day for networking opportunities, starting with welcome coffee, continuing through networking coffee breaks and a three course lunch – and culminating in informal drinks and canapés for all speakers, sponsors and delegates.
David Korn
